The Cal State LA BioSpace initiative was created to foster a culture of inclusive entrepreneurship and promote the bioscience industry in the heart of Los Angeles. We help emerging entrepreneurs turn their scientific discoveries into job-creating businesses.

OUR STORY

 

The Cal State LA BioSpace initiative was created to foster a culture of inclusive entrepreneurship and promote the bioscience industry in the heart of Los Angeles. The initiative aligns with the University’s mission of engagement and service for the public good. Cal State LA BioSpace is providing training, laboratory space and resources for emerging entrepreneurs and their startup companies. Initiatives to create a bioscience ecosystem in Los Angeles date back to the mid-1970s. Those efforts were stymied by weak relational infrastructure and outdated organizational practices, resulting in a drain of human capital to places such as the Bay Area.

calstatela_biostart_ourstory.jpg
 
Biocom
Biocom

press to zoom
UniHealth Foundation
UniHealth Foundation

support a key staff member to successfully launch the LA BioSpace Accelerator program. The LA BioSpace Accelerator Program will help support and grow more than 100 early-stage life science companies, which will create hundreds of critical and high-paying jobs in our region, while advancing vital bio-and life-science work to improve the health and well-being in our community.

press to zoom
The California State University
The California State University

press to zoom
Biocom
Biocom

press to zoom
1/8

LAB BUSINESS PARTNERS

 
Capsida Therapeutics
Capsida Therapeutics

We are a biotechnology company creating a new class of targeted gene therapies for debilitating and life-threatening genetic disorders in both central nervous system (CNS) and non-CNS indications. Current gene therapy approaches have shown dramatic efficacy in several rare diseases but have previously been hindered by imprecise targeting. Capsida is bridging this gap through its innovative approaches and novel gene therapy technologies.

press to zoom
Sequence Analytics.
Sequence Analytics.

We are a bioinformatics company focused on data analysis as a service. Recent advances in assays for next-generation genetic sequencing and molecular biology are creating great opportunities for improving human health. Despite the affordability of such assays, transforming the resulting big data into actionable information remains a challenge. Sequence Analytics overcomes this challenge drawing on its expertise in bio-science, data science, and computer science to provide novel solutions.

press to zoom
Nuanced Health
Nuanced Health

We are a company developing next-generation computational platforms to determine complex biometrics of health, disease, and drug response models. These solutions can aid future drug development and help maximize drug efficacy in humans based on improved preclinical models focused on the human microbiome.

press to zoom
Capsida Therapeutics
Capsida Therapeutics

We are a biotechnology company creating a new class of targeted gene therapies for debilitating and life-threatening genetic disorders in both central nervous system (CNS) and non-CNS indications. Current gene therapy approaches have shown dramatic efficacy in several rare diseases but have previously been hindered by imprecise targeting. Capsida is bridging this gap through its innovative approaches and novel gene therapy technologies.

press to zoom
1/3